About This Deal

10x Genomics acquired Tetramer Shop ApS for $8.5 million, a transaction completed in January 2021, structured as All-cash acquisition of 100% of outstanding shares; total cash consideration $8.5M net of $0.2M cash acquired, including $1.5M contingent consideration (paid 2022).

Tetramer Shop ApS operates in Immunology, is based in Copenhagen, Denmark. Acquisition of Copenhagen, Denmark-based Tetramer Shop ApS, a life sciences technology company that developed and provided reagents for precise monitoring of antigen-specific T cells in research and development. The acquisition closed January 8, 2021 and was announced publicly at 10x's inaugural Xperience event on February 24, 2021.

Strengthen 10x's immunology efforts and accelerate development of T cell receptor-based research tools; technology commercialized with the BEAM-T product.

MHC molecule expertise commercialized via the BEAM-T product to strengthen 10x's immunology portfolio. Immunology / BEAM-T product

Deal Terms

Acquirer
10x Genomics
Target
Tetramer Shop ApS
Value
$8.5 million
Date
January 2021
Type
Acquisition
Status
Ready

Transaction Details

Target HQ
Copenhagen, Denmark
Segment
Immunology
Structure
All-cash acquisition of 100% of outstanding shares; total cash consideration $8.5M net of $0.2M cash acquired, including $1.5M contingent consideration (paid 2022)
Announced
February 24, 2021
Closed
January 8, 2021
Synergies
MHC molecule expertise commercialized via the BEAM-T product to strengthen 10x's immunology portfolio.

In Their Words

We had a solid start to the year highlighted by strong growth across the business and the incredible response to the innovation revealed at our inaugural Xperience event.Serge Saxonov, Co-founder and CEO of 10x Genomics

Advisors

Advisory firms were not disclosed for this transaction.

Related Deals & Entities

Sources: Press release ↗ · Last updated June 26, 2026

See how VectorShift works for your firm

Request Demo